ArticleJournal of enzyme inhibition and medicinal chemistry2022

Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors.

Man Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.